tm logo

Monitor this mark

View On USPTO

ORBEC
Live/Registered
REGISTERED AND RENEWED

on 09 Jan 2024

Last Applicant/ Owned by

SOLIGENIX, INC.

Suite B-10

PRINCETON

NJ

08540

Serial Number

75920960 filed on 16th Feb 2000

Registration Number

2737267 registered on 15th Jul 2003

in the Principal Register

Correspondent Address

Kari Moyer-Henry

Kari Moyer-Henry

17085 Via Del Campo

SAN DIEGO,CA 92127

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

ORBEC

Pharmaceutical preparations for the treatment of graft-versus-host disease

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of graft-versus-host disease

First Use Date in General

30th Nov 1999

First Use Date in Commerce

30th Nov 1999

Mark Details

Serial Number

No 75920960

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 502.304US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
09th Jan 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09th Jan 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09th Jan 2024REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
09th Jan 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12th Jul 2023TEAS SECTION 8 & 9 RECEIVED
15th Jul 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12th Feb 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
01st Oct 2013REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
01st Oct 2013REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01st Oct 2013REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)